Brent earned his B.S. and M.S. in Chemical and Biomedical Engineering from Carnegie Mellon University, where he enrolled at age 16 as a Gates Scholar. He completed his Ph.D. from Johns Hopkins University, where his research focused on developing microfluidic technologies to identify biomarkers of cancer progression and metastasis. This work advanced new approaches for cancer diagnostics and is being commercialized through a university spinout. Brent brings expertise in microfluidics, biomarker discovery, and commercialization.

Nelson earned his B.S. in Chemical Engineering from Worcester Polytechnic Institute and his Ph.D. from Johns Hopkins University, where his research focused on improving the biomanufacturing of life-saving gene therapies and vaccines through nucleic acid analysis, machine learning, and automation. He has previously developed intellectual property licensed and adopted by major biopharma firms and brings deep expertise in computational biology and platform development.